Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-03

Clinical Trial Update: USE THE SYSTEMIC METFORMIN IN MELASMA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating systemic metformin for melasma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Assiut University | Conditions: Melasma | Phase 4 | Status: UNKNOWN